By Karlee Weinmann ( August 18, 2014, 1:19 PM EDT) -- Valeant Pharmaceuticals International Inc. said it will give Allergan Inc. stockholders until the end of the year to decide on its $53 billion hostile bid for the Botox maker, extending the high-stakes buyout contest after a Friday deadline came and went....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.